Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073697 · ClinicalTrials.gov registry record · Phase 4
Treatment of Depression in Adults
A Phase 4 study of Depression, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 290
- Enrollment target
- 2
- Study locations
NCT00073697: Completed Phase 4 study of Depression, sponsored by University of Pittsburgh.
NCT00073697 is a Phase 4 study of Depression that has completed, run by University of Pittsburgh. The registered enrollment target is 290 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073697, a Phase 4 study of Depression, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 290 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine how certain features of depressed individuals affect their responses to depression treatment.
Conditions Studied
Interventions
- DRUG Escitalopram
- BEHAVIORAL Interpersonal Psychotherapy
- OTHER Escitalopram plus IPT
Study Locations (2)
Pennsylvania
- Western Psychiatric Institute and Clinic - Depression Prevention Program - Pittsburgh
Other
- The University of Pisa - Pisa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2003-05 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
What the finished NCT00073697 record still lists
NCT00073697 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Escitalopram is the first listed.
NCT00073697 reports a single indexed study location in Pennsylvania, Other.
Frequently Asked Questions
What is clinical trial NCT00073697 about?
NCT00073697 is a clinical study titled "Treatment of Depression in Adults". This study will determine how certain features of depressed individuals affect their responses to depression treatment.
What is the current status of trial NCT00073697?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 290 participants. The study started on 2003-05. Estimated completion is 2007-10.
What conditions does trial NCT00073697 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00073697?
The interventions under investigation include: Escitalopram (DRUG), Interpersonal Psychotherapy (BEHAVIORAL), Escitalopram plus IPT (OTHER).
Who is sponsoring clinical trial NCT00073697?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00073697 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00073697's enrollment target sits among peer trials
290 154th of 679 higher than 525 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
RECRUITING · Phase 4
-
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia